On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on PRs and Gain Exclusive Benefits with NNW Prime! Click to View Details
WednesdaySep 20, 2017 11:07 am

NetworkNewsBreaks – Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) Has “Buy” Rating Reiterated at Mizuho Securities

Mizuho Securities USA LLC has reiterated its ‘Buy’ rating and price target of $70 on shares of Aerie Pharmaceuticals, Inc.’s (NASDAQ: AERI) stock. The analyst noted the FDA’s recently reported date of the Advisory Committee for Aerie Pharmaceutical's Rhopressa to take place on October 13, 2017. This meeting is considered routine to take place before approval of a new product, specifically a new molecular entity. The analyst also noted another key date to remember in regards to the FDA meeting: October 11, the anticipated date that the FDA will release the background information on Rhopressa. This document typically offers a…

Continue Reading

WednesdaySep 20, 2017 9:14 am

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Director Featured in SmallCapVoice Interview

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that its director of investor relations, Alan Klitenic, was featured in a recent interview with SmallCapVoice.com. In the interview, which can be heard at http://nnw.fm/flQB8, Klitenic discusses CIIX’s recent news, including updates related to the digital currency industry, the company’s plans to launch a Chinese daily video news broadcast from the NYSE floor, CIIX’s recent financial performance and its completion of the record filing process with the Chinese FDA related to its soon-to-be-launched hemp infused skin care line. “I want to emphatically state that CIIX is ready to make sales…

Continue Reading

TuesdaySep 19, 2017 12:08 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on September 19, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: STAF 60.34% – News: Reports $40M in refinancing, closes two new acquisitions VSMR 18.48% – News: Completes The BP360 proximity marketing group acquisition ZPAS 10.00% – News: Provides company update MRMD 9.00% – News: Expands licensing agreement with Tikun Olam IWSY 6.42% – News: Obtains $11M in new funding XELB 4.92% – News: Law firm commences an investigation CLIR 4.86% – News: Completes first installation of The Duplex Plug and Play in Texas BKYI…

Continue Reading

TuesdaySep 19, 2017 12:07 pm

NetworkNewsBreaks – MassRoots, Inc. (MSRT) Plans to Expand Point of Sale System to Nevada Cannabis Market

MassRoots, Inc. (OTCQB: MSRT), one of the leading technology platforms for the cannabis industry, recently reported that it is expanding its point of sale system to the Nevada cannabis market. The decision by Nevada regulators to require all state-licensed cannabis businesses to file regulatory reports via Franwell, Inc.’s METRC system, replacing MJ Freeway’s Leaf Data Systems, effective November 1, 2017, presented MassRoots with an exciting growth opportunity, the company said in a news release. “We believe MassRoots is uniquely positioned to serve cannabis-related businesses in medical and recreational markets across the United States. We estimate our market-share of cannabis consumers…

Continue Reading

TuesdaySep 19, 2017 12:04 pm

NetworkNewsBreaks – Novavax, Inc. (NASDAQ: NVAX) Enrolls First Participant in Phase 1/2 Trial of NanoFlu™ Vaccine

Novavax (NASDAQ: NVAX) said this morning that it has enrolled the first participant in its phase 1/2 clinical trial of its nanoparticle influenza vaccine candidate including its proprietary Matrix-M™ adjuvant (NanoFlu™) in older adults. The primary objective of the trial is to assess the safety and immunogenicity of two concentrations (15 µg or 60 µg) of NanoFlu in comparison to a licensed influenza vaccine, Fluzone® High-Dose (Fluzone HD). Data from the trial is expected by the end of 2017. “Our goal is to deliver a differentiated flu vaccine to the greater than $3 billion global seasonal influenza commercial market and…

Continue Reading

TuesdaySep 19, 2017 10:26 am

NetworkNewsBreaks – Patriot One Technologies (TSX.V: PAT) (OTCQB: PTOTF) Scheduled to Attend Extraordinary Future Conference on September 20

Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) this morning announced that its management team will be presenting, exhibiting and participating in a panel session at the Extraordinary Future Conference on September 20, 2017, in Vancouver. The conference, presented by Cambridge House International, is expected to provide a tremendous opportunity for Patriot One to showcase its award-winning technology to the investment community. CEO Martin Cronin and Director Jeffery Tindale will both be in attendance and available in booth #3 for one-on-one meetings with prospective investors. Additionally, Cronin will be participating in a panel session on security and artificial intelligence at…

Continue Reading

TuesdaySep 19, 2017 9:52 am

NetworkNewsBreaks – PotNetwork Holding, Inc. (POTN) Announces Hurricane Irma Relief Promotion

PotNetwork Holding, Inc. (OTC: POTN) this morning announced that electricity and internet service at Diamond CBD’s corporate headquarters have been restored, and its business is now back up and running smoothly in the wake of what meteorologists have classified as one of the largest recorded hurricanes to hit Florida. As part of the ongoing Hurricane Irma relief efforts, Diamond CBD will be donating 10 percent of all net proceeds for the next three days and offering a 50 percent discount storewide. “Our hearts go out to our community,” Gary Blum, CEO of PotNetwork Holding, stated in the news release. “You…

Continue Reading

TuesdaySep 19, 2017 9:21 am

NetworkNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Retains Consulting Services of Ben Paterson

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced that it has retained the consulting services of Ben Paterson, P.E., to assist in defining the pathway for scale-up, purification and manufacturing strategies related to the company’s cannabinoid biosynthesis program. Paterson brings nearly four decades of experience in developing pharmaceutical manufacturing and purification processes to the InMed team, having previously served as a senior engineering advisor with Pharmaceutical giant Eli Lilly and Company for nearly four decades. “Mr. Paterson brings significant experience in all facets of biosynthesis manufacturing and facility design,” Eric A. Adams, president and…

Continue Reading

MondaySep 18, 2017 12:27 pm

NetworkNewsBreaks – Dragon Victory International Closes IPO with Boustead Securities, LLC as Lead Underwriter

Dragon Victory International Limited has closed its initial public offering (IPO) of 1,421,394 ordinary shares at a public price of $6.00 per share. Gross proceeds of the offering totaled $8,528,363 before expenses, underwriting discount and commissions. Boustead Securities, LLC served as the lead underwriter for the IPO. The Fintech company offering reward-based crowdfunding opportunities and incubation services in China marks Boustead’s third time serving as underwriter for a Chinese company in the last 45 days. Shares of the company’s stock will trade on the Nasdaq Capital Market under the ticker symbol “LYL.” For more information, visit www.DVIntInc.com About Dragon Victory…

Continue Reading

MondaySep 18, 2017 12:03 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on September 18, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: ITUS 91.30% – News: Receives patent covering cancer detection technology CAPR 25.00% – News: Presenting results from HOPE-Duchenne clinical trial at the 22nd International Congress of the World Muscle Society on October 4 MGTI 17.41% – News: Uplists to OTCQB Venture Market LBIX 11.09% – News: Enters definitive arrangement agreement to acquire Liquid Media Group, Inc. PTIE 7.46% – News: Receives $1.8M research grant from NIH; Secures additional $2.2M research grant from National Institute…

Continue Reading

Contact us: 212.418.1217